Page last updated: 2024-09-03

n-methylprotoporphyrin ix and cyclic gmp

n-methylprotoporphyrin ix has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(n-methylprotoporphyrin ix)
Trials
(n-methylprotoporphyrin ix)
Recent Studies (post-2010)
(n-methylprotoporphyrin ix)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
320422,3463334,062

Protein Interaction Comparison

ProteinTaxonomyn-methylprotoporphyrin ix (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alruwaili, N; Deng, W; Huang, A; Kandhi, S; Sun, D; Wolin, MS; Zhang, B1

Other Studies

1 other study(ies) available for n-methylprotoporphyrin ix and cyclic gmp

ArticleYear
Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling.
    PloS one, 2018, Volume: 13, Issue:7

    Topics: Acetylcholine; Animals; Cattle; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Ferrochelatase; HSP90 Heat-Shock Proteins; Nitric Oxide; Nitric Oxide Synthase Type III; Protoporphyrins; Signal Transduction; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents

2018